Perspective Therapeutics (CATX) EBT Margin (2010 - 2023)

Perspective Therapeutics has disclosed EBT Margin across 14 years of filings, most recently posting 343.25% for Q4 2023.

• In Q4 2023, EBT Margin changed N/A year-over-year to 343.25%; the TTM figure through Dec 2023 stood at 3428.1% (changed N/A YoY), while the FY2023 annual figure was 3428.1%, changed N/A from the prior year.
• EBT Margin came in at 343.25% for Q4 2023 at Perspective Therapeutics, up from 473.96% in the prior quarter.
• In the past five years, EBT Margin ranged from a high of 343.25% in Q4 2023 to a low of 531.9% in Q2 2023.
• Average EBT Margin over 5 years is 102.4%, with a median of 52.13% recorded in 2020.
• Year-over-year, EBT Margin surged 9019 bps in 2019 and tumbled 48066 bps in 2023.
• Over 5 years, EBT Margin stood at 40.66% in 2019, then gained by 10 bps to 36.8% in 2020, then sank by 55 bps to 56.96% in 2021, then tumbled by 84 bps to 105.06% in 2022, then surged by 427 bps to 343.25% in 2023.
• Per Business Quant data, the three most recent EBT Margin figures were 343.25% in Q4 2023, 473.96% in Q3 2023, and 531.9% in Q2 2023.